BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29431869)

  • 1. Separation of plasma-derived exosomes into CD3
    Theodoraki MN; Hoffmann TK; Whiteside TL
    Clin Exp Immunol; 2018 Jun; 192(3):271-283. PubMed ID: 29431869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence.
    Theodoraki MN; Hoffmann TK; Jackson EK; Whiteside TL
    Clin Exp Immunol; 2018 Oct; 194(1):67-78. PubMed ID: 30229863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.
    Theodoraki MN; Matsumoto A; Beccard I; Hoffmann TK; Whiteside TL
    Oncoimmunology; 2020; 9(1):1747732. PubMed ID: 32313730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of PD-L1
    Theodoraki MN; Yerneni SS; Hoffmann TK; Gooding WE; Whiteside TL
    Clin Cancer Res; 2018 Feb; 24(4):896-905. PubMed ID: 29233903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
    Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
    Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT.
    Theodoraki MN; Yerneni S; Gooding WE; Ohr J; Clump DA; Bauman JE; Ferris RL; Whiteside TL
    Oncoimmunology; 2019; 8(7):1593805. PubMed ID: 31143513
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune gene expression in head and neck squamous cell carcinoma patients.
    Lecerf C; Kamal M; Vacher S; Chemlali W; Schnitzler A; Morel C; Dubot C; Jeannot E; Meseure D; Klijanienko J; Mariani O; Borcoman E; Calugaru V; Badois N; Chilles A; Lesnik M; Krhili S; Choussy O; Hoffmann C; Piaggio E; Bieche I; Le Tourneau C
    Eur J Cancer; 2019 Nov; 121():210-223. PubMed ID: 31593831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer.
    Beccard IJ; Hofmann L; Schroeder JC; Ludwig S; Laban S; Brunner C; Lotfi R; Hoffmann TK; Jackson EK; Schuler PJ; Theodoraki MN
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer].
    Li H; Liu Y; Liu Y; Liu J; Zhao D; Wang Y; Cheng Y
    Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):755-760. PubMed ID: 29167005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Derived Exosomes (TEX) and Their Role in Immuno-Oncology.
    Whiteside TL; Diergaarde B; Hong CS
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer.
    Hofmann L; Ludwig S; Schuler PJ; Hoffmann TK; Brunner C; Theodoraki MN
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer.
    Chatterjee S; Chatterjee A; Jana S; Dey S; Roy H; Das MK; Alam J; Adhikary A; Chowdhury A; Biswas A; Manna D; Bhattacharyya A
    Carcinogenesis; 2021 Feb; 42(1):38-47. PubMed ID: 32832992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.
    Muller L; Mitsuhashi M; Simms P; Gooding WE; Whiteside TL
    Sci Rep; 2016 Feb; 6():20254. PubMed ID: 26842680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
    Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
    Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer.
    Kim JW; Nam KH; Ahn SH; Park DJ; Kim HH; Kim SH; Chang H; Lee JO; Kim YJ; Lee HS; Kim JH; Bang SM; Lee JS; Lee KW
    Gastric Cancer; 2016 Jan; 19(1):42-52. PubMed ID: 25424150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cargo and Functional Profile of Saliva-Derived Exosomes Reveal Biomarkers Specific for Head and Neck Cancer.
    Hofmann L; Medyany V; Ezić J; Lotfi R; Niesler B; Röth R; Engelhardt D; Laban S; Schuler PJ; Hoffmann TK; Brunner C; Jackson EK; Theodoraki MN
    Front Med (Lausanne); 2022; 9():904295. PubMed ID: 35899209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome.
    Schneider S; Kadletz L; Wiebringhaus R; Kenner L; Selzer E; Füreder T; Rajky O; Berghoff AS; Preusser M; Heiduschka G
    Histopathology; 2018 Oct; 73(4):573-584. PubMed ID: 29742291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer.
    Soo RA; Kim HR; Asuncion BR; Fazreen Z; Omar MFM; Herrera MC; Yun Lim JS; Sia G; Soong R; Cho BC
    Lung Cancer; 2017 Mar; 105():17-22. PubMed ID: 28236980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet Induced Functional Alteration of CD4
    Polasky C; Wendt F; Pries R; Wollenberg B
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
    Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.